FDA's Plan B OTC Switch Decision Deadline Is Sept. 1, HHS' Leavitt Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Sens. Clinton and Murray lift their hold on FDA Acting Commissioner Crawford's nomination after a letter from HHS secretary says FDA action on Barr's Rx-to-OTC switch application is imminent.